K-pop

All NCT 127 Members Sign Renewal Contracts with SM Entertainment

"We Will Continue to Provide Full Support for Their Activities" Set to Make a Comeback with Their 7th Full-Length Album on the 24th of Next Month

KIM HYUNSIK
2026-07-15 10:03:30
[Edaily Starin KIM HYUNSIK Reporter] Boy band NCT 127 (Johnny, Taeyong, Yuta, Doyoung, Jaehyun, Jungwoo, Haechan) will continue their partnership with their agency, SM Entertainment (SM).
NCT 127 (Photo courtesy of SM Entertainment)
SM announced on the 15th, “We have signed contract renewals with all members of NCT 127.”
NCT 127, a sub-unit of SM’s boy group brand NCT, debuted in July 2016. They adopted “127”—representing the longitude of Seoul, the “home of K-pop”—as their group name and have connected with fans around the world. Their representative songs include “Hero” (“Kick It”), “Cherry Bomb,” and “Fact Check.”
SM explained, “We have finalized the contract renewal based on the strong teamwork built over the years and the deep trust between the group and our company.”
The agency added, “Amid the passionate support and love from fans, NCT 127 has established itself as an artist representing K-pop. We thank the members and fans who have shared this dazzling journey with us,” and stated, “We will continue to fully support NCT 127’s activities and remain a steadfast partner.”
NCT 127 will make a comeback with their seventh full-length album on the 24th of next month. Promotions for this album will proceed as a five-member group, excluding Do-young and Jung-woo, who are currently serving in the military.

Economy

Corporation

IT·Science

Economy

[VC’s Pick] “Humans and Robots Working Together”… Holiday Robotics Secures Investment

This week (July 13–16), startups across various sectors—including beauty brands, chat platforms, and AI-based decision-making and data infrastructure—secured investments from venture capital (VC) firm…
2026-07-18 12:08:04

Corporation

[Clinical Update] Celltrion Receives Approval for Phase 1 Trial of Tremfya Biosimilar ‘CT-P68’ in South Korea

Here are the clinical trial and product approval updates that garnered attention in the domestic pharmaceutical and biotech industry this week (July 13–16). (Photo: AI-generated) CelltrionRece…
2026-07-18 07:01:02

IT·Science

PharmaResearch, Equipped with U.S.-Based CG USA, Accelerates Expansion into the U.S. ... What Is the Strategy for Reaching 1 Trillion Won in Sales?

PharmaResearch(214450)is staking its future on expanding into North America—the world’s largest beauty market—despite concerns over stagnant growth in its domestic market. At the same time, attention …
2026-07-17 08:36:02